0.009901 0.005716 0.000000 0.000000 0.011433 0.000000 0.000000 0.000000 0.017905 0.00000 0.00000 0.00000 RESIDUE PRO 7 IS A CIS PROLINE. Leahy, D.J. Axel, R. Hendrickson, W.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 12 90.00 90.00 120.00 101.000 101.000 55.850 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking O4 S -2 96.063 SULFATE ION non-polymer C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Cell(Cambridge,Mass.) CELLB5 0998 0092-8674 68 1145 1162 10.1016/0092-8674(92)90085-Q 1547508 Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution. 1992 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 x-ray 1 1.0 12849.552 T CELL CORECEPTOR CD8 1 man polymer 96.063 SULFATE ION 1 syn non-polymer 18.015 water 23 nat water no no SQFRVSPLDRTWNLGETVELKCQVLLSNPTSGCSWLFQPRGAAASPTFLLYLSQNKPKAAEGLDTQRFSGKRLGDTFVLT LSDFRRENEGYYFCSALSNSIMYFSHFVPVFLPA SQFRVSPLDRTWNLGETVELKCQVLLSNPTSGCSWLFQPRGAAASPTFLLYLSQNKPKAAEGLDTQRFSGKRLGDTFVLT LSDFRRENEGYYFCSALSNSIMYFSHFVPVFLPA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample 9606 Homo sapiens 3.20 61.54 repository Initial release Version format compliance Version format compliance 1 0 1994-01-31 1 1 2008-03-24 1 2 2011-07-13 Y 1992-01-16 REL REL SO4 SULFATE ION HOH water SO4 207 2 SO4 SO4 207 A HOH 1 3 HOH HOH 208 A HOH 2 3 HOH HOH 209 A HOH 3 3 HOH HOH 210 A HOH 4 3 HOH HOH 211 A HOH 5 3 HOH HOH 212 A HOH 6 3 HOH HOH 213 A HOH 7 3 HOH HOH 214 A HOH 8 3 HOH HOH 215 A HOH 9 3 HOH HOH 216 A HOH 10 3 HOH HOH 217 A HOH 11 3 HOH HOH 218 A HOH 12 3 HOH HOH 219 A HOH 13 3 HOH HOH 220 A HOH 14 3 HOH HOH 221 A HOH 15 3 HOH HOH 222 A HOH 16 3 HOH HOH 223 A HOH 17 3 HOH HOH 224 A HOH 18 3 HOH HOH 225 A HOH 19 3 HOH HOH 226 A HOH 20 3 HOH HOH 227 A HOH 21 3 HOH HOH 228 A HOH 22 3 HOH HOH 229 A HOH 23 3 HOH HOH 230 A SER 1 n 1 SER 1 A GLN 2 n 2 GLN 2 A PHE 3 n 3 PHE 3 A ARG 4 n 4 ARG 4 A VAL 5 n 5 VAL 5 A SER 6 n 6 SER 6 A PRO 7 n 7 PRO 7 A LEU 8 n 8 LEU 8 A ASP 9 n 9 ASP 9 A ARG 10 n 10 ARG 10 A THR 11 n 11 THR 11 A TRP 12 n 12 TRP 12 A ASN 13 n 13 ASN 13 A LEU 14 n 14 LEU 14 A GLY 15 n 15 GLY 15 A GLU 16 n 16 GLU 16 A THR 17 n 17 THR 17 A VAL 18 n 18 VAL 18 A GLU 19 n 19 GLU 19 A LEU 20 n 20 LEU 20 A LYS 21 n 21 LYS 21 A CYS 22 n 22 CYS 22 A GLN 23 n 23 GLN 23 A VAL 24 n 24 VAL 24 A LEU 25 n 25 LEU 25 A LEU 26 n 26 LEU 26 A SER 27 n 27 SER 27 A ASN 28 n 28 ASN 28 A PRO 29 n 29 PRO 29 A THR 30 n 30 THR 30 A SER 31 n 31 SER 31 A GLY 32 n 32 GLY 32 A CYS 33 n 33 CYS 33 A SER 34 n 34 SER 34 A TRP 35 n 35 TRP 35 A LEU 36 n 36 LEU 36 A PHE 37 n 37 PHE 37 A GLN 38 n 38 GLN 38 A PRO 39 n 39 PRO 39 A ARG 40 n 40 ARG 40 A GLY 41 n 41 GLY 41 A ALA 42 n 42 ALA 42 A ALA 43 n 43 ALA 43 A ALA 44 n 44 ALA 44 A SER 45 n 45 SER 45 A PRO 46 n 46 PRO 46 A THR 47 n 47 THR 47 A PHE 48 n 48 PHE 48 A LEU 49 n 49 LEU 49 A LEU 50 n 50 LEU 50 A TYR 51 n 51 TYR 51 A LEU 52 n 52 LEU 52 A SER 53 n 53 SER 53 A GLN 54 n 54 GLN 54 A ASN 55 n 55 ASN 55 A LYS 56 n 56 LYS 56 A PRO 57 n 57 PRO 57 A LYS 58 n 58 LYS 58 A ALA 59 n 59 ALA 59 A ALA 60 n 60 ALA 60 A GLU 61 n 61 GLU 61 A GLY 62 n 62 GLY 62 A LEU 63 n 63 LEU 63 A ASP 64 n 64 ASP 64 A THR 65 n 65 THR 65 A GLN 66 n 66 GLN 66 A ARG 67 n 67 ARG 67 A PHE 68 n 68 PHE 68 A SER 69 n 69 SER 69 A GLY 70 n 70 GLY 70 A LYS 71 n 71 LYS 71 A ARG 72 n 72 ARG 72 A LEU 73 n 73 LEU 73 A GLY 74 n 74 GLY 74 A ASP 75 n 75 ASP 75 A THR 76 n 76 THR 76 A PHE 77 n 77 PHE 77 A VAL 78 n 78 VAL 78 A LEU 79 n 79 LEU 79 A THR 80 n 80 THR 80 A LEU 81 n 81 LEU 81 A SER 82 n 82 SER 82 A ASP 83 n 83 ASP 83 A PHE 84 n 84 PHE 84 A ARG 85 n 85 ARG 85 A ARG 86 n 86 ARG 86 A GLU 87 n 87 GLU 87 A ASN 88 n 88 ASN 88 A GLU 89 n 89 GLU 89 A GLY 90 n 90 GLY 90 A TYR 91 n 91 TYR 91 A TYR 92 n 92 TYR 92 A PHE 93 n 93 PHE 93 A CYS 94 n 94 CYS 94 A SER 95 n 95 SER 95 A ALA 96 n 96 ALA 96 A LEU 97 n 97 LEU 97 A SER 98 n 98 SER 98 A ASN 99 n 99 ASN 99 A SER 100 n 100 SER 100 A ILE 101 n 101 ILE 101 A MET 102 n 102 MET 102 A TYR 103 n 103 TYR 103 A PHE 104 n 104 PHE 104 A SER 105 n 105 SER 105 A HIS 106 n 106 HIS 106 A PHE 107 n 107 PHE 107 A VAL 108 n 108 VAL 108 A PRO 109 n 109 PRO 109 A VAL 110 n 110 VAL 110 A PHE 111 n 111 PHE 111 A LEU 112 n 112 LEU 112 A PRO 113 n 113 PRO 113 A ALA 114 n 114 ALA 114 A author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 0.5000000000 0.8660254038 0.0000000000 0.8660254038 -0.5000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 12_555 x,x-y,-z+2/3 crystal symmetry operation 0.0000000000 0.0000000000 37.2333333333 A O SER 6 A O SER 6 A N LYS 21 A N LYS 21 A O CYS 22 A O CYS 22 A N PHE 77 A N PHE 77 A N THR 80 A N THR 80 A O SER 69 A O SER 69 A O LYS 58 A O LYS 58 A N TYR 51 A N TYR 51 A N LEU 52 A N LEU 52 A O CYS 33 A O CYS 33 A O GLN 38 A O GLN 38 A N TYR 91 A N TYR 91 A O SER 98 A O SER 98 A N ILE 101 A N ILE 101 A O LYS 58 A O LYS 58 A N TYR 51 A N TYR 51 A N LEU 52 A N LEU 52 A O CYS 33 A O CYS 33 A O GLN 38 A O GLN 38 A N TYR 91 A N TYR 91 A O TYR 92 A O TYR 92 A N VAL 108 A N VAL 108 1 3.61 0.50 120.30 123.91 A A A NE CZ NH1 ARG ARG ARG 4 4 4 N 1 7.19 0.80 106.30 113.49 A A A CD1 CG CD2 TRP TRP TRP 12 12 12 N 1 -8.56 1.30 127.00 118.44 A A A CB CG CD1 TRP TRP TRP 12 12 12 N 1 -6.36 0.80 107.30 100.94 A A A CE2 CD2 CG TRP TRP TRP 12 12 12 N 1 6.10 0.90 133.90 140.00 A A A CG CD2 CE3 TRP TRP TRP 12 12 12 N 1 6.72 0.80 106.30 113.02 A A A CD1 CG CD2 TRP TRP TRP 35 35 35 N 1 -5.93 0.80 107.30 101.37 A A A CE2 CD2 CG TRP TRP TRP 35 35 35 N 1 A A CG OD2 ASP ASP 75 75 0.142 0.023 1.249 1.391 N 1 A A NE2 CD2 HIS HIS 106 106 -0.067 0.011 1.373 1.306 N 1 A GLN 2 -96.35 30.51 1 A ASN 28 -160.79 108.21 1 A PRO 29 -69.48 -167.30 1 A THR 30 -143.41 -51.10 1 A ARG 40 174.93 -25.44 1 A ALA 42 -94.22 33.60 1 A ALA 43 -173.45 -48.28 1 A LEU 49 -109.18 -64.03 1 A SER 53 -112.02 -161.35 THREE SHORT LOOP REGIONS HAVE POOR ELECTRON DENSITY AND AVERAGE B-FACTORS ABOVE 50A**2: (I) SER 27-SER 31, (II) GLN 54-LYS 56, (III) ARG 40-ALA 43. IN THESE REGIONS SUFFICIENT MAIN-CHAIN DENSITY IS PRESENT TO PROVIDE CONFIDENCE THAT THE COURSE OF THE MAIN-CHAIN IS GENERALLY CORRECT, BUT THE EXACT MAIN-CHAIN TORSION ANGLES AND SIDE-CHAIN POSITIONS ARE NOT WELL DEFINED. 0.192 0.192 2.6 8.0 18872 1 0.0 2.6 8.0 69 1185 5 0 1111 0.011 3.1 model building X-PLOR refinement X-PLOR phasing X-PLOR CD8 (T CELL C0-RECEPTOR, N-TERMINAL 114 RESIDUES) CRYSTAL STRUCTURE OF A SOLUBLE FORM OF THE HUMAN T CELL CO-RECEPTOR CD8 AT 2.6 ANGSTROMS RESOLUTION 1 N N 2 N N 3 N N A ARG 85 A ARG 85 HELX_P A GLU 89 A GLU 89 5 1 5 disulf 2.020 A CYS 22 A SG CYS 22 1_555 A CYS 94 A SG CYS 94 1_555 SURFACE GLYCOPROTEIN SURFACE GLYCOPROTEIN A SER 6 A SER 6 1 A PRO 7 A PRO 7 -0.38 CD8A_HUMAN UNP 1 1 P01732 MALPVTALLLPLALLLHAARPSQFRVSPLDRTWNLGETVELKCQVLLSNPTSGCSWLFQPRGAAASPTFLLYLSQNKPKA AEGLDTQRFSGKRLGDTFVLTLSDFRRENEGYYFCSALSNSIMYFSHFVPVFLPAKPTTTPAPRPPTPAPTIASQPLSLR PEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCNHRNRRRVCKCPRPVVKSGDKPSLSARYV 22 135 1CD8 1 114 P01732 A 1 1 114 4 5 5 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A PHE 3 A PHE 3 A SER 6 A SER 6 A VAL 18 A VAL 18 A VAL 24 A VAL 24 A THR 76 A THR 76 A LEU 81 A LEU 81 A PHE 68 A PHE 68 A LEU 73 A LEU 73 A LYS 58 A LYS 58 A ALA 59 A ALA 59 A THR 47 A THR 47 A LEU 52 A LEU 52 A CYS 33 A CYS 33 A GLN 38 A GLN 38 A GLY 90 A GLY 90 A SER 98 A SER 98 A ILE 101 A ILE 101 A PHE 104 A PHE 104 A LYS 58 A LYS 58 A ALA 59 A ALA 59 A THR 47 A THR 47 A LEU 52 A LEU 52 A CYS 33 A CYS 33 A GLN 38 A GLN 38 A GLY 90 A GLY 90 A SER 98 A SER 98 A VAL 108 A VAL 108 A VAL 110 A VAL 110 BINDING SITE FOR RESIDUE SO4 A 207 Software 4 A ARG 4 A ARG 4 4 10_665 A PRO 7 A PRO 7 4 1_555 A ARG 10 A ARG 10 4 1_555 A LYS 21 A LYS 21 4 4_665 181 P 64 2 2